For clinics that want to source compounded GLP-1 preparations or cGMP RUO peptides through a 503B outsourcing facility, the onboarding process is more involved than simply placing an order. 503B facilities are required to verify the credentials of the healthcare practitioners they sell to, and clinics need to complete a qualification process before they can access supply.

This post walks through the typical steps involved in getting started with a 503B supply partner, what documentation you will need, and what to expect at each stage of the process.

503B outsourcing facilities can only sell their preparations to licensed healthcare practitioners — clinics, hospitals, and other licensed entities that are authorized to administer or dispense prescription medications. They cannot sell to the general public.

To verify that a clinic is a legitimate licensed healthcare entity, 503B facilities conduct a credentialing process before establishing a supply relationship. This is not bureaucratic friction — it is a regulatory requirement that protects both the facility and the clinic.

The credentialing process also helps the 503B facility understand the clinic's needs, verify that the preparations requested are appropriate for the clinic's patient population, and establish the terms of the supply relationship.

Before reaching out to a 503B supply partner, gather the following documentation:

Business credentials:

• Business license or certificate of incorporation
• Federal Employer Identification Number (EIN)
• DEA registration (if applicable to your practice)
• State medical or pharmacy license for the clinic entity

Prescriber credentials:

• Medical license(s) for the prescribing provider(s) at your clinic
• DEA registration for each prescribing provider
• NPI (National Provider Identifier) number for each provider
• Board certifications (if applicable)

Facility credentials:

• Proof of physical clinic address (utility bill, lease agreement, or similar)
• State health department license or certificate of occupancy (if applicable)
• Malpractice insurance certificate

Having these documents organized before you begin the onboarding process will significantly speed up the credentialing review.

Most 503B supply partners require a formal application from new clinic accounts. The application typically collects:

• Clinic name, address, and contact information
• Type of practice (primary care, weight management, med spa, etc.)
• Prescribing providers and their credentials
• Estimated monthly volume for each product category
• Acknowledgment of terms of service and compliance requirements

Some 503B facilities have online application portals; others use paper forms. MedClinic Partners streamlines this process by connecting clinics with vetted supply partners through a single intake process.

After you submit your application, the 503B facility (or its credentialing team) will review your documentation to verify:

• Your clinic is a licensed healthcare entity in good standing
• Your prescribing providers are licensed and in good standing
• Your clinic is located in a state where the 503B facility is licensed to ship
• Your intended use of the preparations is consistent with the facility's product catalog

This review typically takes 3–10 business days, depending on the facility and the completeness of your application. Incomplete applications take longer — make sure you submit all required documentation upfront.

Before your account is activated, you will typically be required to sign a compliance agreement or terms of service that covers:

• Your acknowledgment that you are a licensed healthcare practitioner
• Your agreement to use the preparations only for licensed clinical purposes
• Your agreement to maintain valid prescriptions for all patients who receive the preparations
• Your agreement to store preparations as labeled and use them within their BUD
• Your agreement to report adverse events to the facility and to the FDA
• Your agreement to comply with applicable federal and state laws

Read this agreement carefully. It establishes the terms of your supply relationship and your compliance obligations.

Once your account is approved, you will have access to the facility's product catalog. Review the available preparations and select those that are appropriate for your patient population.

For each product you intend to order, confirm:

• The active ingredient and concentration
• The formulation (lyophilized or liquid)
• The BUD and storage conditions
• The lot release testing performed (potency, sterility, endotoxins)
• The Certificate of Analysis format and availability

If you have questions about specific products or need a formulation that is not in the standard catalog, discuss this with the facility's customer service or clinical team.

With your account approved and your product selection confirmed, you are ready to place your first order. A few practical considerations:

Order quantity: Start with a conservative quantity for your first order — enough to serve your current patient volume for 2–3 weeks. This allows you to evaluate the product quality and the facility's service before committing to larger orders.

Shipping timing: Coordinate your order timing to ensure the preparations arrive with sufficient BUD remaining. If you order on Monday and the preparations ship Tuesday with a 45-day BUD, they will arrive Wednesday with approximately 44 days remaining — plenty of time for most clinic needs.

Receiving protocol: Have your receiving protocol in place before the first shipment arrives. Know who will receive the shipment, how they will inspect it, and where it will be stored.

A 503B supply relationship is not a one-time transaction — it is an ongoing partnership. Manage it proactively:

Reorder before you run out: Track your inventory and reorder with enough lead time to avoid running out. Most 503B facilities have a 1–3 day processing time plus shipping time.

Review CoAs for each lot: When you receive a new lot, review the CoA to confirm it meets your quality expectations.

Communicate changes: If your patient volume changes significantly, your prescribing providers change, or your clinic moves, notify your supply partner promptly.

Stay current on regulatory changes: The regulatory landscape for compounded medications evolves. Stay informed about changes to FDA shortage designations, USP standards, and state regulations that may affect your supply arrangements.

MedClinic Partners simplifies the process of getting connected with vetted 503B supply partners. Rather than researching and applying to multiple facilities independently, clinics can use our platform to:

• Access a network of vetted 503B supply partners
• Complete a single intake process that covers multiple supply options
• Access USA-made cGMP RUO peptides on the same platform as compounding supply
• Get support navigating the credentialing and compliance requirements

Our team works with licensed clinics across all 50 states to help them establish compliant supply relationships for GLP-1 preparations and peptides.

1. Federal Food, Drug, and Cosmetic Act, Section 503B (21 U.S.C. § 353b) — Outsourcing Facilities.
2. U.S. Food and Drug Administration. Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act. FDA, updated 2024.
3. U.S. Food and Drug Administration. Registered Outsourcing Facilities. FDA database, accessed 2026.
4. National Association of Boards of Pharmacy. Compounding Pharmacy Regulation. NABP, 2023.
5. United States Pharmacopeia. USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations. 2023 Revision.

MedClinic Partners connects licensed clinics and 503A pharmacies with vetted 503B supply and USA-made cGMP RUO peptides across all 50 states. Ready to get started? Use the Get Connected form and our team will follow up with eligible licensed clinics.